We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

AMBS Amarantus Bioscience Holdings Inc (CE)

0.00 (0.00%)
May 16 2024 - Closed
Delayed by 15 minutes

Amarantus Bioscience (CE) Financial Summary

The current AMBS market cap is 6.83k. The company's latest EPS is USD -0.0698 and P/E is 0.00.

Year End December 30 2022 20182019202020212022
Total Revenue 020M75k095k
Operating Income -2.84M18.33M-627k-148k-268k
Net Income -10.38M18.38M-627k-10.2M-4.76M
Year End December 30 2022 20182019202020212022
Total Assets 3.48M24.79M24.87M14.71M10.21M
Total Liabilities 31.22M33.74M34.36M34.63M34.87M
Total Equity -27.74M-8.96M-9.48M-19.93M-24.67M

Cash Flow

Year End December 30 2022 20182019202020212022
Operating -6.9M1.02M-83k-9.93M-4.5M
Investing 6.07M-2.03M-81k9.97M4.5M
Financing 781k1.01M163k-45k N/A
Market Cap 6.83k
Price to Earnings Ratio 0.00
Price to Sales Ratio 0
Price to Cash Ratio 0
Price to Book Ratio 0
Dividend Yield -

Share Statistics

Shares Outstanding 68.27M
Average Volume (1 week) 300.4k
Average Volume (1 Month) 211.58k
52 Week Change -91.67%
52 Week High 0.0016
52 Week Low 0.000001
Spread (Intraday) 0 (0%)

Company Info

Company Name Amarantus Bioscience Holdings Inc (CE)
Address 701 s carson street
carson city, nevada 89701
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock